Phase 3 results show the investigational drug norucholic acid is superior to placebo in halting disease progression.

Long-term results of a phase 3 trial show that early rituximab monotherapy significantly delays the need for new treatment in ...

CoV-2’s origin continue to circulate, further complicating efforts to maintain a constructive, evidence-based public ...

Falsely claiming to be a nurse without registration with the Nursing and Midwifery Council is to become a criminal offence, ...

As AI grows more ubiquitous in medicine, it’s showing up in the world of cardiovascular disease prediction too.

Continuing aspirin use perioperatively during subdural hematoma surgery neither increases recurrence risk nor reduces ...

Research found no significant increase in the incidence of new thyroid cancer cases among patients treated with RAIT for ...

Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, ...

Real-world data show encouraging durability of the Rezūm procedure for shrinking prostates but open questions remain.

Remission rates in rheumatoid arthritis vary on the basis of the region in England and Wales, with patients with longer ...

The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...

Prophylactic trimethoprim-sulfamethoxazole lowered serious infection risk in patients with ANCA-associated vasculitis, ...